-+ 0.00%
-+ 0.00%
-+ 0.00%

Sofinnova Partners closes Crossover II fund at €725 million

PUBT·11/16/2026 07:22:45
Listen to the news
Sofinnova Partners closes Crossover II fund at €725 million
  • Sofinnova Partners closed Sofinnova Crossover II at EUR 725 million (USD 815 million), exceeding its original target.
  • The fund targets approximately 15 clinical-stage biopharma and medtech companies, primarily in Europe, with selective investments in other markets.
  • Capital will support clinical development, global expansion and commercialization.
  • Backers include the European Tech Champions Initiative, a fund of funds managed by the European Investment Fund.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sofinnova Partners SAS published the original content used to generate this news brief on November 16, 2026, and is solely responsible for the information contained therein.